Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02876939 · ClinicalTrials.gov registry record · NA
Proprioception and Sensorimotor Control in Hereditary Sensory and Autonomic Neuropathy
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT02876939: Completed NA study, sponsored by NYU Langone Health.
NCT02876939 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02876939, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This project comprises three sets of physiological studies - testing eight specific hypotheses - that will contribute new knowledge on proprioception and motor control in a genetic disorder that affects specific components of the sensory nervous system. I: To investigate the neurophysiological basis for disturbed motor control in Hereditary sensory and autonomic neuropathy (HSAN) III II: To investigate the effects of enhancing cutaneous feedback on motor control in HSAN III III: To investigate the cortical representation of proprioceptive inputs in HSAN III
Interventions
- OTHER kinesiology tape around the hip, knee and ankle joints
- OTHER No kinesiology tape around the hip, knee and ankle joints
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2016-11 |
| Est. Completion | 2019-07-25 |
| Phase | NA |
What the finished NCT02876939 record still lists
NCT02876939 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which kinesiology tape around the hip, knee and ankle joints is the first listed.
NCT02876939 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02876939 about?
NCT02876939 is a clinical study titled "Proprioception and Sensorimotor Control in Hereditary Sensory and Autonomic Neuropathy". This project comprises three sets of physiological studies - testing eight specific hypotheses - that will contribute new knowledge on proprioception and motor control in a genetic disorder that affects specific components of the sensory nervous system. I: To investigate the neurophysiological basi...
What is the current status of trial NCT02876939?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2016-11. Estimated completion is 2019-07-25.
What interventions are being tested in trial NCT02876939?
The interventions under investigation include: kinesiology tape around the hip, knee and ankle joints (OTHER), No kinesiology tape around the hip, knee and ankle joints (OTHER).
Who is sponsoring clinical trial NCT02876939?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02876939's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia